RE: Tech transfer complete31 Mar 2026 16:28
If this works then it doesnt make any sense to give the same patients a higher dose, does it. lol
So recruiting new adult patients for the higher does, and also recruiting paediatric (UK spelling) patients - children. good stuff. I doubt they meant foot patients!
Clinical Trial Progression
Hemogenyx Pharmaceuticals is now ready to initiate recruitment of adult patients for treatment with the second, increased dose level of HG-CT-1 as part of its ongoing Phase 1 clinical trial in R/R AML.
In parallel, the Company will begin recruitment of pediatric patients, who will receive the lowest dose level of HG-CT-1. This marks an important expansion of the clinical program into pediatric populations suffering from R/R AML.